Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation
- PMID: 11303263
- DOI: 10.1086/319984
Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation
Abstract
Retrospective analysis of 303 patients who underwent allogeneic hematopoietic stem cell transplantation identified 35 (11.5%) with adenovirus infection. Among them, 22 received specific therapy. As first-line therapy, 18 were treated with intravenous ribavirin, 3 with cidofovir, and 1 with vidarabine. Moreover, 2 received donor leukocyte infusion in combination with ribavirin, and 1 received it after failing to respond to other therapies. Seven survived (31.8%; 3 of 13 who received ribavirin alone and 2 of 3 who received cidofovir). Among the 5 patients treated with combined strategies, 2 who received donor leukocyte infusions showed clearance of all symptoms. Acute graft-versus-host disease grade > or = 3 (P = .01) and a long delay between infection and treatment (P = .05) correlated with a greater risk of treatment failure. In conclusion, ribavirin and vidarabine are ineffective options, particularly for patients at who are high risk of acquiring disseminated adenovirus disease. Conversely, cidofovir or donor leukocyte infusions seem to be encouraging approaches if initiated early.
Similar articles
-
Successful treatment of adenovirus disease with intravenous cidofovir in an unrelated stem-cell transplant recipient.Clin Infect Dis. 1999 Mar;28(3):690-1. doi: 10.1086/517222. Clin Infect Dis. 1999. PMID: 10194105 No abstract available.
-
Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.Bone Marrow Transplant. 2003 Mar;31(6):481-6. doi: 10.1038/sj.bmt.1703798. Bone Marrow Transplant. 2003. PMID: 12665844
-
Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir.Transpl Infect Dis. 2007 Jun;9(2):108-13. doi: 10.1111/j.1399-3062.2006.00184.x. Transpl Infect Dis. 2007. PMID: 17461995
-
Treatment of adenovirus disease in stem cell transplant recipients with cidofovir.Biol Blood Marrow Transplant. 2007 Jan;13(1):74-81. doi: 10.1016/j.bbmt.2006.08.040. Biol Blood Marrow Transplant. 2007. PMID: 17222755 Review.
-
Antiviral therapy for adenovirus infections.Antiviral Res. 2006 Sep;71(2-3):172-80. doi: 10.1016/j.antiviral.2006.04.007. Epub 2006 May 2. Antiviral Res. 2006. PMID: 16698093 Review.
Cited by
-
Respiratory Virus Infections in Hematopoietic Cell Transplant Recipients.Front Microbiol. 2019 Jan 9;9:3294. doi: 10.3389/fmicb.2018.03294. eCollection 2018. Front Microbiol. 2019. PMID: 30687278 Free PMC article. Review.
-
Management of adenovirus in children after allogeneic hematopoietic stem cell transplantation.Adv Hematol. 2013;2013:176418. doi: 10.1155/2013/176418. Epub 2013 Oct 28. Adv Hematol. 2013. PMID: 24288536 Free PMC article. Review.
-
Selenomethionine Inhibited HADV-Induced Apoptosis Mediated by ROS through the JAK-STAT3 Signaling Pathway.Nutrients. 2024 Jun 20;16(12):1966. doi: 10.3390/nu16121966. Nutrients. 2024. PMID: 38931321 Free PMC article.
-
Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivo.PLoS Pathog. 2015 Feb 6;11(2):e1004673. doi: 10.1371/journal.ppat.1004673. eCollection 2015 Feb. PLoS Pathog. 2015. PMID: 25658827 Free PMC article.
-
Antiviral Drugs in Adenovirus-Induced Keratoconjunctivitis.Microorganisms. 2022 Oct 12;10(10):2014. doi: 10.3390/microorganisms10102014. Microorganisms. 2022. PMID: 36296290 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
